Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'dopamine D3 receptor' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 94 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Segman, RH; Heresco-Levy, U; Finkel, B; Goltser, T; Shalem, R; Schlafman, M; Dorevitch, A; Yakir, A; Greenberg, D; Lerner, A; Lerer, B
      Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia

      MOLECULAR PSYCHIATRY
    2. Basile, VS; Ozdemir, V; Masellis, M; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, FM; Petronis, A; Kennedy, JL
      Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    3. Okura, M; Fujiki, N; Ripley, B; Takahashi, S; Amitai, N; Mignot, E; Nishino, S
      Narcoleptic canines display periodic leg movements during sleep

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    4. Arranz, MJ; Mancama, D; Kerwin, RW
      Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    5. Richtand, NM; Goldsmith, RJ; Nolan, JE; Berger, SP
      The D3 dopamine receptor and substance dependence

      JOURNAL OF ADDICTIVE DISEASES
    6. Sotnikova, TD; Gainetdinov, RR; Grekhova, TV; Rayevsky, KS
      Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study)

      PHARMACOLOGICAL RESEARCH
    7. Collier, DA; Osborne, S; Munro, J; Kerwin, RW
      Pharmacogenetic methods in schizophrenia

      INTERNATIONAL REVIEW OF PSYCHIATRY
    8. Malhotra, AK
      The genetics of schizophrenia

      CURRENT OPINION IN PSYCHIATRY
    9. Liao, DL; Yeh, YC; Chen, HM; Chen, H; Hong, CJ; Tsai, SJ
      Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

      NEUROPSYCHOBIOLOGY
    10. Hillefors, M; von Euler, G
      Pharmacology of [H-3]R(+)-7-OH-DPAT binding in the rat caudate-putamen

      NEUROCHEMISTRY INTERNATIONAL
    11. Ozdemir, V; Basile, VS; Masellis, M; Kennedy, JL
      Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes

      JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    12. Basile, VS; Masellis, M; McIntyre, RS; Meltzer, HY; Lieberman, JA; Kennedy, JL
      Genetic dissection of atypical antipsychotic-induced weight gain: Novel preliminary data on the pharmacogenetic puzzle

      JOURNAL OF CLINICAL PSYCHIATRY
    13. Richtand, NM; Woods, SC; Berger, SP; Strakowski, SM
      D3 dopamine receptor, behavioral sensitization, and psychosis

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    14. Elvidge, G; Jones, I; McCandless, F; Asherson, P; Owen, MJ; Craddock, N
      Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: Results of analysis and meta-analysis

      AMERICAN JOURNAL OF MEDICAL GENETICS
    15. Ozdemir, V; Shear, NH; Kalow, W
      What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?

      DRUG SAFETY
    16. Wicke, K; Garcia-Ladona, J
      The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    17. Krebs, MO; Guillin, O; Bourdel, MC; Schwartz, JC; Olie, JP; Poirier, MF; Sokoloff, P
      Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia

      MOLECULAR PSYCHIATRY
    18. Basile, VS; Ozdemir, V; Masellis, M; Walker, ML; Heltzer, HY; Lieberman, JA; Potkin, SG; Alva, G; Kalow, W; Macciardi, FM; Kennedy, JL
      A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    19. Petronis, A
      The genes for major psychosis: Aberrant sequence or regulation?

      NEUROPSYCHOPHARMACOLOGY
    20. Quik, M; Police, S; He, L; Di Monte, DA; Langston, JW
      Expression of D-3 receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: Effect of levodopa treatment

      NEUROSCIENCE
    21. Heiden, A; Schussler, P; Itzlinger, U; Leisch, F; Scharfetter, J; Gebhardt, C; Fuchs, K; Willett, M; Nilsson, L; Miller-Reiter, E; Stompe, T; Meszaros, K; Sieghart, W; Hornik, K; Kasper, S; Aschauer, HN
      Association studies of candidate genes in bipolar disorders

      NEUROPSYCHOBIOLOGY
    22. Elmhurst, JL; Xie, ZD; O'Dowd, BF; George, SR
      The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerization

      MOLECULAR BRAIN RESEARCH
    23. Cichon, S; Nothen, MM; Rietschel, M; Propping, P
      Pharmacogenetics of schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    24. Kremer, I; Rietschel, M; Dobrusin, M; Mujaheed, M; Murad, I; Blanaru, M; Bannoura, I; Muller, DJ; Schulze, TG; Reshef, A; Gathas, S; Schwab, S; Wildenauer, D; Bachner-Melman, R; Belmaker, RH; Maier, W; Ebstein, RP
      No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population

      AMERICAN JOURNAL OF MEDICAL GENETICS
    25. Eichhammer, P; Albus, M; Borrmann-Hassenbach, M; Schoeler, A; Putzhammer, A; Frick, U; Klein, HE; Rohrmeier, T
      Association of dopamine D3-receptor gene variants with neuroleptic inducedakathisia in schizophrenic patients: A generalization of Steen's study on DRD3 and tardive dyskinesia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    26. Henderson, AS; Korten, AE; Jorm, AF; Jacomb, PA; Christensen, H; Rodgers, B; Tan, X; Easteal, S
      COMT and DRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders

      AMERICAN JOURNAL OF MEDICAL GENETICS
    27. Barr, CL; Wigg, KG; Wu, J; Zai, C; Bloom, S; Tannock, R; Roberts, W; Malone, M; Schachar, R; Kennedy, JL
      Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder

      AMERICAN JOURNAL OF MEDICAL GENETICS
    28. Masi, G; Brovedani, P
      Tourette's syndrome in children: Neurobiological issues in pathophysiology

      PANMINERVA MEDICA
    29. Joober, R; Toulouse, A; Benkelfat, C; Lal, S; Bloom, D; Labelle, A; Lalonde, P; Turecki, G; Rouleau, GA
      DRD3 and DAT1 genes in schizophrenia: an association study

      JOURNAL OF PSYCHIATRIC RESEARCH
    30. Richtand, NM; Logue, AD; Welge, JA; Perdiue, J; Tubbs, LJ; Spitzer, RH; Sethuraman, G; Geracioti, TD
      The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine

      BRAIN RESEARCH
    31. Segman, RH; Heresco-Levy, U; Finkel, B; Inbar, R; Neeman, T; Schlafman, M; Dorevitch, A; Yakir, A; Lerner, A; Goltser, T; Shelevoy, A; Lerer, B
      Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2C(ser) and DRD3(gly) alleles to susceptibility

      PSYCHOPHARMACOLOGY
    32. Bigliani, V; Mulligan, RS; Acton, PD; Ohlsen, RI; Pike, VW; Ell, PJ; Gacinovic, S; Kerwin, RW; Pilowsky, LS
      Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [I-123]epidepride single photon emission tomography (SPET) study

      PSYCHOPHARMACOLOGY
    33. Segman, R; Neeman, T; Heresco-Levy, U; Finkel, B; Karagichev, L; Schlafman, M; Dorevitch, A; Yakir, A; Lerner, A; Shelevoy, A; Lerer, B
      Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia

      MOLECULAR PSYCHIATRY
    34. Hondo, H; Spitzer, RH; Grinius, B; Richtand, NM
      Quantification of dopamine D3 receptor mRNA level associated with the development of amphetamine-induced behavioral sensitization in the rat brain

      NEUROSCIENCE LETTERS
    35. Kuzhikandathil, EV; Oxford, GS
      Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells

      JOURNAL OF NEUROSCIENCE
    36. Serretti, A; Lattuada, E; Cusin, C; Lilli, R; Lorenzi, C; Smeraldi, E
      Dopamine D3 receptor gene not associated with symptomatology of major psychoses

      AMERICAN JOURNAL OF MEDICAL GENETICS
    37. Barr, CL; Wigg, KG; Pakstis, AJ; Kurlan, R; Pauls, D; Kidd, KK; Tsui, LC; Landor, P
      Genome scan for linkage to Gilles de la Tourette syndrome

      AMERICAN JOURNAL OF MEDICAL GENETICS
    38. Stober, G; Hebebrand, J; Cichon, S; Bruss, M; Bonisch, H; Lehmkuhl, G; Poustka, F; Schmidt, M; Remschmidt, H; Propping, P; Nothen, MM
      Tourette syndrome and the norepinephrine transporter gene: Results of a systematic mutation screening

      AMERICAN JOURNAL OF MEDICAL GENETICS
    39. Rutter, M; Silberg, J; O'Connor, T; Simonoff, E
      Genetics and child psychiatry: II - Empirical research findings

      JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY AND ALLIED DISCIPLINES
    40. Zaworski, PG; Alberts, GL; Pregenzer, JF; Bin Im, W; Slightom, JL; Gill, GS
      Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells

      BRITISH JOURNAL OF PHARMACOLOGY
    41. HAWI Z; MCCABE U; STRAUB RE; ONEILL A; KENDLER KS; WALSH D; GILL M
      EXAMINATION OF NEW AND REPORTED DATA OF THE DRD3 MSCL POLYMORPHISM - NO SUPPORT FOR THE PROPOSED ASSOCIATION WITH SCHIZOPHRENIA/

      Molecular psychiatry
    42. BARR CL; SANDOR P
      CURRENT STATUS OF GENETIC-STUDIES OF GILLES-DE-LA-TOURETTE-SYNDROME

      Canadian journal of psychiatry
    43. Deutch, AY; Bubser, M; Young, CD
      Psychostimulant-induced fos protein expression in the thalamic paraventricular nucleus

      JOURNAL OF NEUROSCIENCE
    44. SPURLOCK G; WILLIAMS J; MCGUFFIN P; ASCHAUER HN; LENZINGER E; FUCHS K; SIEGHART WC; MESZAROS K; FATHI N; LAURENT C; MALLET J; MACCIARDI F; PEDRINI S; GILL M; HAWI Z; GIBSON S; JAZIN EE; YANG HT; ADOLFSSON R; PATO CN; DOURADO AM; OWEN MJ
      EUROPEAN MULTICENTER ASSOCIATION STUDY OF SCHIZOPHRENIA - A STUDY OF THE DRD2 SER311CYS AND DRD3 SER9GLY POLYMORPHISMS

      American journal of medical genetics
    45. EKMAN A; NISSBRANDT H; HEILIG M; DIJKSTRA D; ERIKSSON E
      CENTRAL ADMINISTRATION OF DOPAMINE D3 RECEPTOR ANTISENSE TO RAT - EFFECTS ON LOCOMOTION, DOPAMINE RELEASE AND [H-3]SPIPERONE BINDING

      Naunyn-Schmiedeberg's archives of pharmacology
    46. ALSOBROOK JP; PAULS DL
      MOLECULAR APPROACHES TO CHILD PSYCHOPATHOLOGY

      Human biology
    47. ALBERTS GL; PREGENZER JF; BINIM W
      CONTRIBUTIONS OF CYSTEINE-114 OF THE HUMAN D3 DOPAMINE-RECEPTOR TO LIGAND-BINDING AND SENSITIVITY TO EXTERNAL OXIDIZING-AGENTS

      British Journal of Pharmacology
    48. KARAYIORGOU M; GOGOS JA
      DISSECTING THE GENETIC COMPLEXITY OF SCHIZOPHRENIA

      Molecular psychiatry
    49. EGAN MF; WEINBERGER DR
      NEUROBIOLOGY OF SCHIZOPHRENIA

      Current opinion in neurobiology
    50. KARAYIORGOU M; GOGOS JA
      A TURNING-POINT IN SCHIZOPHRENIA GENETICS

      Neuron
    51. ROBERTSON MM; STERN JS
      THE GILLES-DE-LA-TOURETTE-SYNDROME

      Critical reviews in neurobiology
    52. ALSOBROOK JP; PAULS DL
      THE GENETICS OF TOURETTE-SYNDROME

      Neurologic clinics
    53. BRETT PM; CURTIS D; ROBERTSON MM; GURLING HMD
      NEURORECEPTOR SUBUNIT GENES AND THE GENETIC SUSCEPTIBILITY TO GILLES-DE-LA-TOURETTE SYNDROME

      Biological psychiatry
    54. WEEKS RA; TURJANSKI N; BROOKS DJ
      TOURETTES-SYNDROME - A DISORDER OF CINGULATE AND ORBITOFRONTAL FUNCTION

      Quarterly Journal of Medicine
    55. CHAPERON F; THIEBOT MH
      EFFECTS OF DOPAMINERGIC D3-RECEPTOR-PREFERRING LIGANDS ON THE ACQUISITION OF PLACE CONDITIONING IN RATS

      Behavioural pharmacology
    56. VAHIDANSARI F; ROBERTSON GS
      7-OH-DPAT DIFFERENTIALLY REVERSES CLOZAPINE-INDUCED AND HALOPERIDOL-INDUCED INCREASES IN FOS-LIKE IMMUNOREACTIVITY IN THE RODENT FOREBRAIN

      European journal of neuroscience
    57. ODONOVAN MC; OWEN MJ
      THE MOLECULAR-GENETICS OF SCHIZOPHRENIA

      Annals of medicine
    58. DURANY N; THOME J; PALOMO A; FOLEY P; RIEDERER P; CRUZSANCHEZ FF
      HOMOZYGOSITY AT THE DOPAMINE D3 RECEPTOR GENE IN SCHIZOPHRENIC-PATIENTS

      Neuroscience letters
    59. HURLEY MJ; STUBBS CM; JENNER P; MARSDEN CD
      D3 RECEPTOR EXPRESSION WITHIN THE BASAL GANGLIA IS NOT AFFECTED BY PARKINSONS-DISEASE

      Neuroscience letters
    60. GAINETDINOV RR; SOTNIKOVA TD; GREKHOVA TV; RAYEVSKY KS
      SIMULTANEOUS MONITORING OF DOPAMINE, ITS METABOLITES AND TRANS-ISOMEROF ATYPICAL NEUROLEPTIC DRUG CARBIDINE CONCENTRATIONS IN STRIATAL DIALYSATES OF CONSCIOUS RATS

      Progress in neuro-psychopharmacology & biological psychiatry
    61. TANAKA T; IGARASHI S; ONODERA O; TANAKA H; TAKAHASHI M; MAEDA M; KAMEDA K; TSUJI S; IHDA S
      ASSOCIATION STUDY BETWEEN SCHIZOPHRENIA AND DOPAMINE D3 RECEPTOR GENEPOLYMORPHISM

      American journal of medical genetics
    62. HIGUCHI S; MURAMATSU T; MATSUSHITA S; MURAYAMA M
      NO EVIDENCE OF ASSOCIATION BETWEEN STRUCTURAL POLYMORPHISM AT THE DOPAMINE D3 RECEPTOR LOCUS AND ALCOHOLISM IN THE JAPANESE

      American journal of medical genetics
    63. ROTHSCHILD LG; BADNER J; CRAVCHIK A; GERSHON ES; GEJMAN PV
      NO ASSOCIATION DETECTED BETWEEN A D-3 RECEPTOR GENE-EXPRESSED VARIANTAND SCHIZOPHRENIA

      American journal of medical genetics
    64. MCGUFFIN P; OWEN MJ
      MOLECULAR-GENETIC STUDIES OF SCHIZOPHRENIA

      Cold Spring Harbor Symposia on Quantitative Biology
    65. KAMEI J; SAITOH A
      INVOLVEMENT OF DOPAMINE D2 RECEPTOR-MEDIATED FUNCTIONS IN THE MODULATION OF MORPHINE-INDUCED ANTINOCICEPTION IN DIABETIC MOUSE

      Neuropharmacology
    66. BOUNDY VA; LU LH; MOLINOFF PB
      DIFFERENTIAL COUPLING OF RAT D2 DOPAMINE-RECEPTOR ISOFORMS EXPRESSED IN SPODOPTERA-FRUGIPERDA INSECT CELLS

      The Journal of pharmacology and experimental therapeutics
    67. SEBENS JB; KOCH T; KORF J
      LACK OF CROSS-TOLERANCE BETWEEN HALOPERIDOL AND CLOZAPINE TOWARDS FOS-PROTEIN INDUCTION IN RAT FOREBRAIN REGIONS

      European journal of pharmacology
    68. LEVESQUE D
      AMINOTETRALIN DRUGS AND D-3 RECEPTOR FUNCTIONS - WHAT MAY PARTIALLY SELECTIVE D-3 RECEPTOR LIGANDS TELL US ABOUT DOPAMINE D-3 RECEPTOR FUNCTIONS

      Biochemical pharmacology
    69. CROCQ MA; BUGUET A; BISSER S; BURGERT E; STANGHELLINI A; UYANIK G; DUMAS M; MACHER JP; MAYEROVA A
      BALI AND MSPI POLYMORPHISMS OF THE DOPAMINE D3 RECEPTOR GENE IN AFRICAN BLACKS AND CAUCASIANS

      Human heredity
    70. NISSBRANDT H; EKMAN A; ERIKSSON E; HEILIG M
      DOPAMINE D3 RECEPTOR ANTISENSE INFLUENCES DOPAMINE SYNTHESIS IN RAT-BRAIN

      NeuroReport
    71. LAHTI RA; ROBERTS RC; TAMMINGA CA
      D-2-FAMILY RECEPTOR DISTRIBUTION IN HUMAN POSTMORTEM TISSUE - AN AUTORADIOGRAPHIC STUDY

      NeuroReport
    72. BURRIS KD; PACHECO MA; FILTZ TM; KUNG MP; KUNG HF; MOLINOFF PB
      LACK OF DISCRIMINATION BY AGONISTS FOR D-2 AND D-3 DOPAMINE-RECEPTORS

      Neuropsychopharmacology
    73. CHOKKA PR; BAKER GB; BORNSTEIN RA; DEGROOT CM
      THE BIOCHEMISTRY OF TOURETTES-SYNDROME

      Metabolic brain disease
    74. CROCQ MA; DUVAL F; MAYEROVA A; SOKOLOFF P; MOKRANI MC; MACHER JP
      CLINICAL AND FUNCTIONAL CORRELATES OF A DOPAMINE D3 RECEPTOR POLYMORPHISM

      Human psychopharmacology
    75. GAINETDINOV RR; SOTNIKOVA TD; GREKHOVA TV; RAYEVSKY KS
      ESTIMATION OF THE INTERSTITIAL-FREE CONCENTRATION OF THE PUTATIVE DOPAMINE D3 RECEPTOR-SELECTIVE AGONIST 7-OH-DPAT IN THE DORSAL STRIATUM OF FREELY MOVING RATS

      Neuroscience letters
    76. HIGUCHI S; MURAMATSU T; ARAI H; HAYASHIDA M; SASAKI H; TROJANOWSKI JQ
      POLYMORPHISMS OF DOPAMINE-RECEPTOR AND TRANSPORTER GENES AND PARKINSONS-DISEASE

      Journal of neural transmission
    77. RAYEVSKY KS; GAINETDINOV RR; GREKHOVA TV; SOTNIKOVA TD
      REGULATION OF DOPAMINE RELEASE AND METABOLISM IN RAT STRIATUM IN-VIVO- EFFECTS OF DOPAMINE-RECEPTOR ANTAGONISTS

      Progress in neuro-psychopharmacology & biological psychiatry
    78. BAKER GB; CHOKKA PR; BORNSTEIN RA
      NEUROCHEMICAL AND SOME RELATED PSYCHOPHARMACOLOGICAL ASPECTS OF TOURETTES-SYNDROME - AN UPDATE

      JOURNAL OF PSYCHOPHARMACOLOGY
    79. SCHWARTZ JC; GRIFFON N; DIAZ J; LEVESQUE D; SAUTEL F; SOKOLOFF P; SIMON P; COSTENTIN J; GARRIDO F; MANN A; WERMUTH C
      THE D-3 RECEPTOR AND ITS RELEVANCE IN PSYCHIATRY

      International clinical psychopharmacology
    80. RICHTAND NM; KELSOE JR; SEGAL DS; KUCZENSKI R
      REGIONAL QUANTIFICATION OF D1, D2, AND D3 DOPAMINE-RECEPTOR MESSENGER-RNA IN RAT-BRAIN USING A RIBONUCLEASE PROTECTION ASSAY

      Molecular brain research
    81. GILBERT DB; COOPER SJ
      7-OH-DPAT INJECTED INTO THE ACCUMBENS REDUCES LOCOMOTION AND SUCROSE INGESTION - D-3 AUTORECEPTOR-MEDIATED EFFECTS

      Pharmacology, biochemistry and behavior
    82. BOUNDY VA; PACHECO MA; GUAN W; MOLINOFF PB
      AGONISTS AND ANTAGONISTS DIFFERENTIALLY REGULATE THE HIGH-AFFINITY STATE OF THE D2(L) RECEPTOR IN HUMAN EMBRYONIC KIDNEY 293-CELLS

      Molecular pharmacology
    83. YOSHIDA N; YOSHIKAWA T; HOSOKI K
      A DOPAMINE D-3 RECEPTOR AGONIST, 7-OH-DPAT, CAUSES VOMITING IN THE DOG

      Life sciences
    84. WALLACE DR; BOOZE RM
      IDENTIFICATION OF D-3 AND SIGMA-RECEPTORS IN THE RAT STRIATUM AND NUCLEUS-ACCUMBENS USING (+ -)-7-HYDROXY-N,N-DI-N-[H-3] PROPYL-2-AMINOTETRALIN AND CARBETAPENTANE/

      Journal of neurochemistry
    85. KULA NS; BALDESSARINI RJ; KEBABIAN JW; NEUMEYER JL
      S-(-APORPHINES ARE NOT SELECTIVE FOR HUMAN D-3 DOPAMINE-RECEPTORS())

      Cellular and molecular neurobiology
    86. NUTT DJ
      PUTTING THE A IN ATYPICAL - DOES ALPHA(2)-ADRENOCEPTOR ANTAGONISM ACCOUNT FOR THE THERAPEUTIC ADVANTAGE OF NEW ANTIPSYCHOTICS

      JOURNAL OF PSYCHOPHARMACOLOGY
    87. WATTS SW; GACKENHEIMER SL; GEHLERT DR; COHEN ML
      AUTORADIOGRAPHIC COMPARISON OF [I-125] LSD-LABELED 5-HT2A RECEPTOR DISTRIBUTION IN RAT AND GUINEA-PIG BRAIN

      Neurochemistry international
    88. MANT R; WILLIAMS J; ASHERSON P; PARFITT E; MCGUFFIN P; OWEN MJ
      RELATIONSHIP BETWEEN HOMOZYGOSITY AT THE DOPAMINE D3 RECEPTOR GENE AND SCHIZOPHRENIA

      American journal of medical genetics
    89. PROPPING P; NOTHEN MM; KORNER J; RIETSCHEL M; MAIER W
      ASSOCIATION TESTS IN PSYCHIATRIC-DISORDER S - CONCEPTS AND FINDINGS

      Nervenarzt
    90. CHUMPRADIT S; KUNG MP; VESSOTSKIE J; FOULON C; MU M; KUNG HF
      IODINATED 2-AMINOTETRALINS AND 3-AMINO-1-BENZOPYRANS - LIGANDS FOR DOPAMINE D2 AND D3 RECEPTORS

      Journal of medicinal chemistry
    91. HILLEFORSBERGLUND M; VONEULER G
      PHARMACOLOGY OF DOPAMINE D-3 RECEPTORS IN THE ISLANDS OF CALLEJA OF THE RAT USING QUANTITATIVE RECEPTOR AUTORADIOGRAPHY

      European journal of pharmacology
    92. KURLAN R
      HYPOTHESIS-II - TOURETTES-SYNDROME IS PART OF A CLINICAL SPECTRUM THAT INCLUDES NORMAL BRAIN-DEVELOPMENT

      Archives of neurology
    93. PAGLIUSI S; CHOLLETDAEMERIUS A; LOSBERGER C; MILLS A; KAWASHIMA E
      CHARACTERIZATION OF A NOVEL EXON WITHIN THE D3 RECEPTOR GENE GIVING RISE TO AN MESSENGER-RNA ISOFORM EXPRESSED IN RAT-BRAIN

      Biochemical and biophysical research communications
    94. JONSSON E; LANNFELT L; SOKOLOFF P; SCHWARTZ JC; SEDVALL G
      LACK OF ASSOCIATION BETWEEN SCHIZOPHRENIA AND ALLELES IN THE DOPAMINE-D3 RECEPTOR GENE

      Acta psychiatrica Scandinavica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 05:04:39